ADENOVIRAL VECTOR MEDIATED IN VIVO GENE TRANSFER OF BDNF PROMOTE FUNCTIONAL RECOVERY AFTER FACIAL NERVE CRUSH INJURY

안면신경 압박손상 후 Adenovirus 매개 BDNF 유전자 전달을 통한 신경손상 회복에 관한 연구

  • Yang, Byoung-Eun (Department of Oral and Maxillofacial Surgery, College of Medicine, Hallym University) ;
  • Lee, Jong-Ho (Department of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Seoul National University)
  • 양병은 (한림대학교 의과대학 구강악안면외과학교실) ;
  • 이종호 (서울대학교 치의학대학원 구강악안면외과학교실)
  • Published : 2006.08.31

Abstract

Objectives Despite considerable advances in technique, experience and skill, the precise place of surgery in the treatment of facial nerve injury remains uncertain. We designed a facial nerve crush injury model in rats and evaluated the recovery of crushed nerve which is the most common injury type of facial nerve using adenovirus vector mediated in vivo gene transfer of Brain derived neurotrophic factor(BDNF). Materials and methods In 48 Sprague Dawley rats, we made a facial nerve crush injury model to main trunk before the furcation, and injected a $10^{11}$pfu adenoviral BDNF in experimental group(BDNF adenoviral injection group; ad-BDNF) and $3{\mu}l$ saline in control group(Saline injection group; saline). After a period of regeneration from 10 to 40 days, nerve regeneration was evaluated with functioinal test (vibrissae and ocular movement), electrophysiologic study(threshold, peak voltage, conduction velocity) and histomorphometric study of axon density. Results Vibrissae and ocular movement, threshold and conduction velocity improved as time elapse in both group, however axon density was increased significantly only in experimental group. Functional test in 10 days and 20 days showed no difference between experimental group and control group. Vibrissae movement, threshold, conduction velocity and axon density in 30 days revealed that the regeneration in quality of experimental group was significantly superior to that of control group. Conclusion In general, there is tendency for nerve regeneration in experimental group (BDNF-adenovirus injection group) during 40 days, functional recovery was detected successfully after facial nerve crush in 30 days postoperatively.

Keywords

References

  1. Petit F, Paraskevas A, Minns AB, Lee WP, Lantieri LA: Face transplantation: where do we stand? Plast Reconstr Surg 2004;113:1429-1433 https://doi.org/10.1097/01.PRS.0000112747.85388.39
  2. Gimenezy Ribotta M, Revah F, Pradier L, Loquet I, Mallet J, Privat A: Prevention of motoneuron death by adenovirus-mediated neurotrophic factors. J Neurosci Res 1997;48:281-285 https://doi.org/10.1002/(SICI)1097-4547(19970501)48:3<281::AID-JNR11>3.0.CO;2-4
  3. Hadlock TA, Heaton J, Cheney M, Mackinnon SE: Functional recovery after facial and sciatic nerve crush injury in the rat. Arch Facial Plast Surg 2005;7:17-20 https://doi.org/10.1001/archfaci.7.1.17
  4. Mattsson P, Janson AM, Aldskogius H, Svensson M: Nimodipine promotes regeneration and functional recovery after intracranial facial nerve crush. J Comp Neurol 2001;437:106-117 https://doi.org/10.1002/cne.1273
  5. Adams JH DL, eds. Greenfield's Neuropathology. New York: NY: Oxford University Press; 1992
  6. Liu J, Farmer JD, Jr., Lane WS, Friedman J, Weissman I, Schreiber SL: Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991;66:807-815 https://doi.org/10.1016/0092-8674(91)90124-H
  7. Barde YA, Edgar D, Thoenen H: Purification of a new neurotrophic factor from mammalian brain. Embo J 1982;1:549-553
  8. Oppenheim RW, Yin QW, Prevette D, Yan Q: Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death. Nature 1992;360:755-757 https://doi.org/10.1038/360755a0
  9. Sendtner M, Holtmann B, Kolbeck R, Thoenen H, Barde YA: Brainderived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 1992;360:757-759 https://doi.org/10.1038/360757a0
  10. Boyd JG, Gordon T: A dose-dependent facilitation and inhibition of peripheral nerve regeneration by brain-derived neurotrophic factor. Eur J Neurosci 2002;15:613-626 https://doi.org/10.1046/j.1460-9568.2002.01891.x
  11. Yan Q, Elliott J, Snider WD: Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature 1992;360:753-755 https://doi.org/10.1038/360753a0
  12. Markus A, Patel TD, Snider WD: Neurotrophic factors and axonal growth. Curr Opin Neurobiol 2002;12:523-531 https://doi.org/10.1016/S0959-4388(02)00372-0
  13. Meyer M, Matsuoka I, Wetmore C, Olson L, Thoenen H: Enhanced synthesis of brain-derived neurotrophic factor in the lesioned peripheral nerve: different mechanisms are responsible for the regulation of BDNF and NGF mRNA. J Cell Biol 1992;119:45-54 https://doi.org/10.1083/jcb.119.1.45
  14. Funakoshi H, Frisen J, Barbany G, Timmusk T, Zachrisson O, Verge VM, Persson H: Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve. J Cell Biol 1993;123:455-465 https://doi.org/10.1083/jcb.123.2.455
  15. Shirley DM, Williams SA, Santos PM: Brain-derived neurotrophic factor and peripheral nerve regeneration: a functional evaluation. Laryngoscope 1996;106:629-632 https://doi.org/10.1097/00005537-199605000-00021
  16. Jones LL, Oudega M, Bunge MB, Tuszynski MH: Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury. J Physiol 2001;533:83-89 https://doi.org/10.1111/j.1469-7793.2001.0083b.x
  17. Poduslo JF, Curran GL: Permeability at the blood-brain and bloodnerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Brain Res Mol Brain Res 1996;36:280-286 https://doi.org/10.1016/0169-328X(95)00250-V
  18. Koda M, Hashimoto M, Murakami M, Yoshinaga K, Ikeda O, Yamazaki M, Koshizuka S, Kamada T, Moriya H, Shirasawa H, Sakao S, Ino H: Adenovirus vector-mediated in vivo gene transfer of brain-derived neurotrophic factor (BDNF) promotes rubrospinal axonal regeneration and functional recovery after complete transection of the adult rat spinal cord. J Neurotrauma 2004;21:329-337 https://doi.org/10.1089/089771504322972112
  19. Peltekian E, Parrish E, Bouchard C, Peschanski M, Lisovoski F: Adenovirus-mediated gene transfer to the brain: methodological assessment. J Neurosci Methods 1997;71:77-84 https://doi.org/10.1016/S0165-0270(96)00128-8
  20. Smith GM, Romero MI: Adenoviral-mediated gene transfer to enhance neuronal survival, growth, and regeneration. J Neurosci Res 1999;55:147-157 https://doi.org/10.1002/(SICI)1097-4547(19990115)55:2<147::AID-JNR2>3.0.CO;2-8
  21. Hermens WT, Giger RJ, Holtmaat AJ, Dijkhuizen PA, Houweling DA, Verhaagen J: Transient gene transfer to neurons and glia: analysis of adenoviral vector performance in the CNS and PNS. J Neurosci Methods 1997;71:85-98 https://doi.org/10.1016/S0165-0270(96)00129-X
  22. Haase G, Pettmann B, Vigne E, Castelnau-Ptakhine L, Schmalbruch H, Kahn A: Adenovirus-mediated transfer of the neurotrophin-3 gene into skeletal muscle of pmn mice: therapeutic effects and mechanisms of action. J Neurol Sci 1998;160 Suppl 1:S97-105 https://doi.org/10.1016/S0022-510X(98)00207-X
  23. Kobayashi NR, Bedard AM, Hincke MT, Tetzlaff W: Increased expression of BDNF and trkB mRNA in rat facial motoneurons after axotomy. Eur J Neurosci 1996;8:1018-1029 https://doi.org/10.1111/j.1460-9568.1996.tb01588.x
  24. Boyd JG, Gordon T: Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury. Mol Neurobiol 2003;27:277-324 https://doi.org/10.1385/MN:27:3:277
  25. Kamijo Y, Koyama J, Oikawa S, Koizumi Y, Yokouchi K, Fukushima N, Moriizumi T: Regenerative process of the facial nerve: rate of regeneration of fibers and their bifurcations. Neurosci Res 2003;46:135-143 https://doi.org/10.1016/S0168-0102(03)00035-X
  26. Sugita K, Hirota T, Iguchi I, Mizutani T: Comparative study of the pressure of various aneurysm clips. J Neurosurg 1976;44:723-727 https://doi.org/10.3171/jns.1976.44.6.0723
  27. Zawadzka M, Kaminska B: Immunosuppressant FK506 affects multiple signaling pathways and modulates gene expression in astrocytes. Mol Cell Neurosci 2003;22:202-209 https://doi.org/10.1016/S1044-7431(03)00036-8